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1. Introduction 
For approval of active substances Regulation (EC) No 1107/2009 (here referred to as PPP 
Regulation) provides in Annex II “Procedure and criteria for the approval of active 
substances, safeners and synergists pursuant to Chapter II” that, amongst other things, 
active substances, safeners and synergists (here referred to as active substances) cannot be 
approved if they are classified or have to be classified for carcinogenicity, mutagenicity or 
reproductive toxicity (CMR), category 1A or 1B hazard classes in accordance with the 
Classification Labelling and Packaging (CLP) Regulation, unless exposure is negligible (for 
C and R, 1A or 1B). The PPP Regulation specifies in the approval procedures that the applicant 
shall submit a dossier to the Rapporteur Member State (RMS), who shall assess the dossier and 
present the results of that assessment in the draft assessment report (DAR). The RMS shall 
submit its DAR to the Commission and the European Food Safety Authority (EFSA). EFSA is 
required to make the DAR available within 30 days to the other Member States for a 60-day 
commenting period. In parallel, the DAR is also made publicly available by EFSA. EFSA have 
to adopt a conclusion within 120-150 days of the end of the commenting period on whether the 
active substance can be expected to meet the approval criteria and send this to the Commission 
and Member States. The Commission then has to present a review report and a draft 
regulation (proposed decision) to the Standing Committee on the Food Chain and Animal 
Health within 6 months of receipt of the conclusion.  
For classification of active substances Regulation (EC) No 1272/2008 (here referred to as CLP 
Regulation), requires that proposals for Harmonized Classification and Labelling (C&L) of 
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active substances in PPP should be submitted to the European Chemicals Agency (ECHA). 
The proposals follow an agreed procedure with an initial accordance check which is 
followed by a public consultation process and subsequent consideration of the proposal by 
the Committee for Risk Assessment (RAC). The legislation requires the RAC to adopt an 
opinion on the proposal. 
The comments received during public consultation may have an impact on the subsequent 
steps of the process. In a dialogue between the dossier submitter, RAC rapporteurs and 
ECHA secretariat the best way to proceed will be decided in cases where substantial 
comments and/or new information are received during the public consultation. In certain 
cases this may lead to the withdrawal of the dossier and the submission of a revised version 
by the Member State or to another public consultation on a re-submitted dossier based on 
the RAC opinion. In other cases the RAC may indicate that the submitted information is 
insufficient and that it does not allow an opinion to be issued on the classification and 
labelling.1  
The legislation requires the RAC to adopt an opinion on the proposal within 18 months. The 
opinion is forwarded by ECHA to the Commission for a final decision on the harmonized 
classification and labelling of the substance to be taken via comitology. 
While the underlying database supporting a specific substance’s assessment presented in 
the DAR and CLH proposal can be assumed to be broadly similar, the nature (i.e., the level 
of detail reported/presentation of study results) may differ as a result of the differing 
guidance and objectives of the two processes. The judgments made in relation to a particular 
piece of information may differ when considered under the hazard-based CLH process 
compared with the risk-based authorization process. Therefore, the DAR for approval and 
the CLH dossier for classification and labelling decisions may require different preparation 
and presentation of the underlying data, and not all data will be equally relevant for both 
decision-making procedures. To meet the regulatory objectives efficiently, both procedures 
require dossier formats specifically tailored to the different regulatory processes. The PPP 
Regulation requires a specific dossier structure and the CADDY electronic format system is 
used, whereas under the CLP Regulation there is a legal requirement for use of IUCLID 
(IUCLID 5 being the current version) which is a quite different electronic submission system 
using structured files. 
A close linkage between these two processes is therefore highly desirable, especially for new 
active substances without existing, legally binding CLH in Annex VI of the CLP Regulation, 
or for active substances already classified which have to be re-evaluated in the light of new 
data that may necessitate revision of the existing classification and labelling.  
The classification and labelling of active substances for human health endpoints is not only a 
principal criterion for the approval of active substances, safeners and synergists, but also the 
main basis for decisions on other regulatory categories and criteria established in the PPP 
Regulation namely: 
                                                                 
1 ECHA conclusions CLH Workshop 16 February 2011, ECHA 
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 consideration as low-risk active substances;  
 identification as candidates for substitution; 
 decisions on the interim criteria for endocrine disrupting properties that may cause 
adverse effects in humans; 
 decisions on the relevance of metabolites that can occur in groundwater; 
 decisions on toxicity with regard to defined persistence, bioaccumulation and toxicity 
(PBT) properties; 
 setting risk mitigation measures for operators, workers, bystanders and residents in the 
procedure of national authorization of PPPs.  
Therefore, a finalized harmonized C&L for active substances is, in many cases, a 
prerequisite for the harmonized authorization of PPP and mutual recognition according to 
the PPP Regulation. Furthermore, a final classification and labelling of the active substance 
is also essential for comparable decisions on approval of active substances in plant 
protection products under the PPP Regulation and biocidal products under the new Biocidal 
Products Regulation which will be published in 2012. Although the new Biocidal Products 
Regulation was not the subject of the workshop, part of the workshop results could have a 
positive impact on the classification procedure of biocides since the new Regulation will 
include cut-off criteria comparable to the PPP Regulation. 
2. Workshop results 
The main objectives of the workshop were to discuss options on how the two processes can 
most efficiently be aligned at the level of Member State authorities, EFSA and ECHA in the 
plenary session and in two main breakout group topics: 
i. streamlining and integration of the review procedures for active substances in PPP for 
approval under the PPP Regulation and for classification and labelling under the CLP 
Regulation. 
ii. scientific and practical issues in the interpretation of carcinogenicity, mutagenicity and 
reproductive toxicity studies and reporting regarding the criteria and practicalities in 
preparation of dossiers under both legislative frameworks.  
The workshop started with a plenary session with lectures to introduce the two regulatory 
frameworks and provide technical information on the individual processes before entering 
into detailed discussions in two breakout groups. The presentations given in this first 
plenary session are available in Annex III of the workshop report which is published on the 
European Commission website: 
(http://ec.europa.eu/food/plant/protection/evaluation/docs/report_berlin_april2011_en.pdf). 
3. Streamlining and integration of the review procedures  
Before the workshop, EFSA and ECHA had already started an exchange of information in 
order to identify practical solutions for processing proposals for CLH (especially for the 
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CMR hazard classes) concerning active substances in PPP quickly and efficiently and, as far 
as possible, within the same timeline as that of the risk assessment procedure. Based on a 
discussion paper prepared in February 2010 by ECHA on the cooperation between ECHA 
and EFSA in the assessment of hazard properties of active substances in PPP under the CLP 
and PPP Regulations, and a discussion at the meeting in June 2010 of EFSA’s Network with 
the Member State authorities in the area of pesticides, the Pesticide Steering Committee, the 
following scope was proposed as a starting point for the discussion in breakout group 1: 
 Streamlining and integration of the review procedures for active substances in PPP for 
approval under the PPP Regulation and for classification and labelling under the CLP 
Regulation. 
The main goals of breakout group 1 were 
1. to inform the discussion on how the two processes could most efficiently be aligned 
between Rapporteur Member States (RMS), EFSA and ECHA;  
2. to consider the anticipated workloads stemming from the PPP active substance 
programmes in relation to the capacity of the EFSA/ECHA process with a view to 
ensuring that appropriate planning, management and prioritization procedures can be 
established; 
3. to raise awareness in Member States (i.e., Competent Authorities (CAs) responsible for 
the evaluation of active substances in PPP and for their classification and labelling, 
respectively) and to communicate the importance of the issue and possible solutions; 
4. to provide feedback on a draft working document on processes “Cooperation between 
CAs in Member States, ECHA and EFSA in the assessment of CMR properties of active 
substances in PPP under Regulations (EC) No 1107/2009 and 1272/2008” (based on the 
ECHA discussion paper from February 2011 regarding the preparation of the CLH 
report and the cooperation of the dossier submitter with RAC). 
3.1. How the two processes could be aligned 
Based on discussions held during the workshop, the following practical solutions were 
identified for new or existing active substances without existing legal C&L or for substances 
with legal C&L which have to be re-evaluated in consideration of new data for C&L: 
 The Rapporteur Member State for the active substance should identify as early as 
possible in the evaluation process for approval or renewal of approval (preferably at the 
end of the completeness check) the need for an initiation of the CLH procedure under 
the CLP Regulation and should make a notification of intention for the CLH procedure 
to ECHA at an early stage. The notifier should be encouraged to indicate the 
classification and labelling in the PPP dossier. 
 Specific issues, such as substance ID, for both approval under the PPP Regulation and 
inclusion under Annex VI of the CLP Regulation, should be solved as soon as possible 
by direct contact between the RMS and EFSA/ECHA. 
 The RMS for the active substance could prepare in parallel: 
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 the DAR for EFSA for developing conclusions on possible fulfilment of the 
approval criteria to be sent to the Commission 
 a proposal for harmonized classification and labelling for ECHA in accordance 
with the CLP Regulation, as well as ECHA’s guidance and format requirements for 
developing a RAC opinion on classification and labelling 
 Ideally, the CLH report should be ready and submitted one month before the DAR 
in order to allow time for the accordance check. 
 EFSA and ECHA should aim to conduct their public consultations at the same time 
(EFSA for 60 days and ECHA for 45 days) to streamline the processes. 
 The time schedule in EFSA for adopting the conclusions on fulfilment of the approval 
criteria is 120-150 days from the end of the commenting process, after which the 
Commission has 6 months for preparing its review report and a draft regulation. 
 ECHA and EFSA will follow closely and potentially participate in the deliberations 
during each other's review process. To avoid duplication of work, leading actors of both 
processes will keep each other informed on the progress, identify critical issues as early 
as possible and, if necessary, organize joint discussions in dedicated ad hoc groups 
assembling capable experts for the issue under consideration from both processes.  
 RAC will start the consideration for agreement on the opinion as early as possible 
Although RAC formally has 18 months for providing their opinion, the scheduled 
procedure should allow the adoption of the opinion on adequate classification well 
before expiry of the 6 month period in which the Commission develops its review 
report and draft regulation after receiving EFSA’s conclusion on whether the active 
substance is expected to fulfil the approval criteria in the PPP Regulation. 
The above mentioned parallel, and partly joint, processing of the proposals – conclusion on 
expected fulfilment of the approval criteria by EFSA and on harmonized classification and 
labelling by ECHA – would assure that the RAC’s opinion on fulfilment of the classification 
criteria (in particular for the CMR hazard classes) is delivered in time for the Commission to 
develop its review report and draft regulation (i.e., within 6 months of receiving EFSA’s 
conclusions). 
3.2. Workloads from the PPP programmes in relation to the capacity of the ECHA  
In order to ensure that any agreed aligned processes can deliver conclusions on harmonized 
C&L in an efficient and timely manner there was also a need to consider: 
 the anticipated workloads stemming from the PPP active substance process and 
 the capacity of the ECHA process to deliver conclusions taking into account available 
resources and other demands on those resources. 
Proposals for harmonized classification of PPP active substances may be submitted from the 
following EFSA work programmes: 
 new active substances: it is possible that a considerable number of new active 
substance/ safener and synergist applications will be submitted each year; 
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 renewal programme for existing active substances: this programme will start in 2013 
(R2) and continue with substance assessments being delivered in 2015 (R3), and each 
year thereafter for the foreseeable future; 
 review of safeners and synergists: likely to be low numbers of assessments submitted to 
EFSA from 2016 or beyond. 
In addition, it is possible that limited numbers of requests may arise on an ad hoc basis as 
part of the Commission obligations to establish, by 14 December 2013, a list of (approved) 
substances that satisfy the criteria for candidates for substitution. 
A proportion of the existing substances will already have harmonized classifications (i.e., 
mainly in the renewal programme for existing active substances). However, the use of 
hazard classification, as part of the criteria for approval and in relation to other areas (e.g., 
candidates for substitution/interim endocrine disruption criteria), may result in the 
generation of further studies to support updates/revision of existing proposals. The 
demands from the existing substance ‘renewal’ programme and priorities could be 
estimated at an early stage based on pre-submission information (updating statements). 
Initial information on priority for CLH consideration for new active substances could be 
gathered in the pre-submission process. 
Therefore, consideration should be given to the establishment of agreed procedures for the 
management and prioritization of PPP active substances entering the process together with 
transparent procedures for monitoring their progress and the delivery of conclusions. The 
need for linkages between the annual planning and resource management processes within 
EFSA and ECHA should also be taken into account. 
3.3. Raise awareness in Member States  
The need for communication of the importance of a harmonized classification process in the 
approval process for PPP active substances was emphasized in the workshop. It was noted 
that it might be challenging to establish communication structures between the two 
processes at the national level due to the number of and coordination among involved 
governmental ministries and agencies. 
However, the role of existing structures within the PPP assessment and decision-making 
processes in communication and raising awareness should be considered. 
In particular, the roles and responsibilities of the following in communicating/planning/ 
disseminating information should be considered, as well as the linkages between them: 
 the Pesticide Steering Committee;  
 the Standing Committee on the Food Chain and Animal Health; 
 the Committee for Risk Assessment (RAC); 
 the Competent Authorities for REACH and CLP (CARACAL, to advise the European 
Commission and ECHA on questions related to REACH and CLP). 
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There is a need to identify ways to facilitate continuous cooperation/scientific knowledge 
exchange at the national level among experts from different concerned authorities.  
A critical element for ensuring a proper coordination is a full understanding of the different 
procedures according to the PPP and CLP Regulations and cooperation of the Member State 
acting as rapporteur under the EFSA process and dossier submitter under the ECHA process. 
The RAC procedures are based on the full involvement of the dossier submitter, which does 
not end with the submission of the dossier. The dossier submitter is involved in the 
assessment of the comments received during the public consultation and should facilitate 
the RAC discussion by providing clarifications if needed. 
CARACAL is composed of representatives from Member State competent authorities for 
REACH and CLP, representatives from competent authorities of EEA-EFTA countries, as 
well as a number of observers from non-EU countries, international organizations and 
stakeholders. The EUROPEAN COMMISSION (DG Enterprise and Industry and DG 
Environment) will prepare a proposal to adapt the CLH in Annex VI to the CLP Regulation 
to technical progress every year based on the opinions received from ECHA's RAC for 
harmonized classification and labelling. 
ECHA is currently updating the process and cooperation between RAC and the MS as 
dossier submitters based on the outcome of the workshop “On the Way to CLH” held in 
February 2011.  
The discussions at this workshop covered issues and procedural changes such as: 
 changes in the Registry of Intentions; 
 accordance check streamlining; 
 facilitation of communication between dossier submitters, ECHA and RAC;  
 dealing with comments received during public consultation; 
 withdrawal and resubmission procedures in the case of receipt of new crucial 
information during public consultation or even at a later stage. 
The Member State acting as rapporteur under the EFSA process and dossier submitter under 
the ECHA process should be fully familiar with the RAC process. ECHA will provide 
information if required. A full internal coordination among the MS experts and CAs is 
particularly essential when there is more than one CA involved in the process.  
3.4. Finalize a draft working document on processes  
During the workshop the working procedures were discussed intensively. The outcomes of 
the discussions are reported in the presentations as included in the report published on the 
Commission website: http://ec.europa.eu/food/plant/protection/evaluation/docs/report_ 
berlin_april2011_en.pdf.  
The workshop did not conclude on a draft working procedure, however, to keep up the 
momentum, the workshop Organizing Committee took the initiative to develop a draft 
working document on processes which will serve as a basis for the first projects in the 
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parallel processing of dossiers and which has been presented to Member States’ competent 
authorities. 
4. Scientific and practical issues in the interpretation of studies and 
reporting 
Based on the criteria for the approval of active substances in PPP under the PPP Regulation 
and the classification criteria regarding "Health hazards" under the CLP Regulation, the 
following scope was proposed as a starting point for the discussion in breakout group 2: 
 scientific and practical issues in the assessment and interpretation of carcinogenicity, 
mutagenicity and reproductive toxicity (CMR) studies, and requirements concerning 
adequate preparation of dossiers (with respect to scientific content and formatting 
according to the PPP Regulation and the CLP Regulation). 
The main goals of breakout group 2 were: 
1. to recommend solutions regarding formatting problems with documents/dossiers 
(e.g., how to facilitate compilation of CLH dossiers by the Rapporteur Member Stat, 
how to integrate additional relevant documents from the pesticide process in these 
dossiers, possibility of profits for CLH dossiers based on experience with previous 
pesticide assessments); 
2. to discuss possibilities and practicalities for submission of IUCLID 5 dossiers in 
addition to the dossiers for active substances under the PPP Regulation to facilitate the 
preparation of dossiers for classification and labelling, as well as possible assistance for 
approval; 
3. to improve harmonized interpretation and reporting of carcinogenicity, mutagenicity 
and reproductive toxicity studies, discuss scientific principles of interpretation of 
relevant studies. This shall contribute to avoiding conflicting interpretations and 
different reporting of the same studies under the two processes. 
4.1. Recommended solutions regarding formatting problems  
The workshop participants recognized that although in the current DARs the purpose of the 
substance evaluation is mainly to derive a basis for risk assessment (i.e., deriving 
NOAELs/LOAELs and setting reference doses) this issue requires reconsideration due to the 
new cut-off criteria settled in the PPP Regulation. The main intention of the CLH report is 
hazard identification (i.e., assessment of the nature and severity of effects and the dose 
response relationship to be compared with a defined set of criteria) including the specific 
comparison of the available evidence with the CLP classification criteria.  
Currently the structure of the DAR is under discussion and will be revised in the next few 
years. A proposal for this revision was presented the break out group session. 
For CMR substances, the DAR under the PPP Regulation would require a similar 
assessment (hazard identification and comparison with the criteria) to that required for the 
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CLP report, and therefore, the same document can cover both assessments. For other hazard 
classes, the DAR should also be the basis for the CLH proposal, and therefore, it seems 
logical to integrate this information as well. 
The workshop participants considered that for a better common scientific understanding, it 
is essential to implement the same structure in the reporting and formatting of the DAR and 
CLH reports. In fact, the proposed solution is to incorporate the weight of evidence and 
comparison with the CLP criteria to be included in the CLH report as one of the 
chapters/documents/elements of the new DAR structure. Additional considerations are 
needed for facilitating the description of the key studies results in a way that could cover the 
needs for the DAR and for the CLH report. The structure of the CLH report is defined in the 
legislation (reference to Chemical Safety Assessment and Report under REACH) and 
described further in the CLP guidance, which allows the required flexibility to 
accommodate the dossier's specific needs. It should be kept in mind that the CLH process 
also applies to biocides and industrial chemicals, that some substances have several uses 
and that the CLH structure must be similar for all types of chemicals. However, as the 
structure and level of detail of the CLH report will be periodically updated based on RAC 
experience when processing the CLH dossiers, the specific input gained during the 
discussions of the new DAR format can be used in the periodic revisions of the CLH report 
format. In addition, specific guidance for preparing the CLH report as the hazard 
identification chapter of the DAR for PPP active substances is required.  
As an outcome of the ECHA workshop “On the way to CLH”, RAC, with the support of the 
ECHA secretariat, is currently revising the structure of its opinions and particularly of the 
background document presenting the detailed justification of the RAC opinion. The 
background document is based on the original CLH report. On the other hand, the PPP 
experts are currently discussing possible improvements to the structure of the DAR and 
dossier. It was considered that ECHA and EFSA should be in close contact during these 
developments in order to ensure mutual feedback and coordination between both 
processes. 
To complement the proposal mentioned above, it was also recommended that when 
drafting the DAR annexes related to the robust study summaries and the assessment 
summaries which constitute the basis for the hazard identification and risk assessment, both 
intentions should be kept in mind and addressed, allowing the use of the text related to the 
hazard identification as the starting point for the CLH report and DAR hazard identification 
chapter. 
It was also mentioned that currently some DARs do not contain a proper presentation of the 
evidence related to the hazard identification and its comparison with the CLP classification 
criteria. It was highlighted that this is an essential part of the CLH report and should be 
specifically considered. The current RAC experience might offer further suggestions for 
reporting the weight of evidence and the comparison of data with the criteria, and some 
examples were presented during the workshop. 
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4.2. Practicalities for submission of pesticide dossiers in IUCLID format   
The OECD Expert Group on the Electronic Exchange of Pesticide Data makes an effort to 
support the harmonization of the international submission formats used for pesticide 
registration (Caddy, eIndex, ePRISM). This harmonized format is called GHSTS (Global 
Harmonized Submission Transport Schema) and will be finalized in 2012. At present it is 
not possible to submit a full document-based pesticide dossier from a company to the 
authority using IUCLID 5, which is endpoint record-based. The answer should be found by 
ECHA by evaluating the proposals collected in a public consultation.  
 The objective of this public consultation, organized in collaboration between OECD and 
the ECHA, is to receive input and exchange ideas on the next generation of the IUCLID 
software from stakeholders not represented at the OECD IUCLID User Group Expert 
Panel. 
 After a few years of experience in using IUCLID 5 as a tool for collecting, storing and 
exchanging information on chemicals in the OECD, and for national and regional 
chemical review programmes, it is time to plan for the next generation of the IUCLID 
software and to adapt it to fit the evolving needs of a growing user community. 
Example developments could be the extension of IUCLID to specific information 
relevant for pesticides or information on exposure and risks related to uses of 
substances, or the development of several user interfaces adapted for a specific purpose 
connected to the same core database. 
This next generation of the IUCLID software might also be useful for the submission of a 
future PPP dossier and/or a DAR, as well as the CLH report. The Harmonized Templates 
were implemented to store structured data from studies on an endpoint record level. This 
technique is used in IUCLID.  
 The content of the XML files according to the Harmonized Templates shall replace the 
Tier II summary level (Word, PDF) to prevent a duplicate lifecycle management by the 
companies of a text and of the corresponding structured data set.  
 Today the authorities have to produce a duplicate lifecycle management of a CLH text 
and a technical CLH dataset in parallel over a long period. Why is it necessary to 
produce two versions of a CLH dossier, a text processor CLH dossier and the technical 
IUCLID data file?  
A mutual understanding of the needs and workload implications was the starting point for 
this discussion. There is a clear benefit in having an IUCLID 5 dossier for all substances, 
including PPP active substances, but on the other hand there is an additional workload for 
the CAs when preparing an IUCLID 5 dossier from a dossier presented in a different format. 
Over the long-term the OECD approach may provide a fully compatible solution and this 
was recognized as the best solution. 
The workshop participants recognized that the role of the PPP CAs should be equivalent to 
the role of the REACH/CLP and biocide CAs: to revise and update the IUCLID 5 dossier 
presented by the relevant companies. Therefore, before a fully compatible submission 
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system is developed, the alternative should be to request the companies to include in their 
submission an IUCLID 5 dossier for the studies relevant for classification and labelling. 
4.3. Improve harmonized interpretation and reporting  
The ECHA and EFSA processes represent the scientific assessments of the available 
information in order to establish solid scientifically based conclusions for supporting the 
decision-making process by the European Commission. ECHA and EFSA have specific 
mandates, defined in their respective regulations. The workshop discussions and the 
conclusions presented below should be understood and implemented taking into account 
the different and independent roles and mandates of ECHA and EFSA, and the European 
Commission.  
The conclusion that the CMR-related cut-off criteria for active substances to be included in 
PPP are met is based on a conclusive scientific assessment on the substance with regard to 
the fulfilment of the approval criteria proposed by EFSA2 and on the opinion of ECHA. In 
order to support such a conclusion early in the evaluation process under the PPP 
Regulation, common interpretation of the classification criteria for CMR properties in both 
contexts (EFSA and ECHA) would be an important prerequisite. Both agencies should 
cooperate to achieve a common interpretation of the underlying studies, particularly in 
terms of reliability and relevance, and to explain any divergence and deviation if needed.  
Classification as CMR category 1A or 1B will exclude an active substance from approval and 
subsequent use in PPPs (unless exposure is negligible in case of CR), whereas classification 
as CMR category 2 allows approval. The credibility of the scientific assessments of CMR 
properties could suffer if conclusions under the PPP Regulation and under the CLP 
Regulation were inconsistent, e.g.: 
 if a CLP decision adopted by the Commission on the basis of a RAC opinion (CMR 
category 1A or 1B) made it necessary to revoke an active substance approval, which 
was adopted at an earlier time point or  
 if active substance approvals were declined earlier in the process on the grounds of an 
RMS or EFSA proposal for CMR category 1A or 1B classification, but later a CLP 
decision adopted by the Commission on the basis of the RAC opinion resulted in CMR 
category 2 classification which would have allowed the approval of the active 
substance.  
Similarly, divergences in the answer to the question of whether a substance should be 
classified as CMR category 2 or should not be classified would also have consequences at PPP 
authorization level and even at active substance approval level (relevance of groundwater 
metabolites). Harmonized application of the CLP criteria for CMR classification within the EU 
Member States and by different Expert Meetings is therefore essential.  
                                                                 
2 Article 12(2) of Regulation 1107/2009 lays down that "…the Authority shall adopt a conclusion in the light of current 
scientific and technical knowledge using guidance documents available at the time of application on whether the 
active substance can be expected to meet the approval criteria provided for in Article 4… " 
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Although detailed criteria for hazard classification and labelling of substances have been 
laid down under the CLP Regulation, particularly the specific criteria for CMR classification 
requires expert judgement and consideration of many different factors (e.g., weight and 
strength of evidence, mechanism or mode of action and its relevance to humans) included in 
the available relevant experimental data and the additional reliable information.  
Based on the experience from various national and international Expert Meetings, it seems 
obvious that the interpretation of CMR data from experimental tests and epidemiological 
studies by different Expert Meetings in ECHA and EFSA, i.e., the RAC and the Pesticide 
Risk Assessment Peer Review (PRAPeR) meeting, does not necessarily lead to the same 
opinion and proposal on classification, even though the same data have been evaluated. The 
current RAC experience already indicates a significant number of borderline cases as being 
particularly problematic. The workshop participants considered that the optimal solution 
would be an involvement of the experts at an early stage. This requires coordination within 
the rapporteur MS under the PPP process, as well as between EFSA and ECHA. Ideally, the 
RAC opinion on harmonized classification and labelling should be the basis for the EFSA 
conclusion on the cut-off criteria related to CMR properties; if this is not feasible in all cases, 
the RAC opinion on the CMR classification should be at least available for the Commission 
for their decision-making process on the approval. There is a special need for a common 
interpretation of the criteria for the classification of substances for reproductive toxicity 
(paternal and maternal toxicity, consideration of potency and setting of specific 
concentration limits, developmental versus lactation effects, etc.). 
When expert judgement and consideration of many different factors (e.g., weight and 
strength of evidence, mechanism or mode of action and its relevance to humans) is needed, 
common scientific understanding is essential under both regulations.  
The workshop participants considered that the cooperation of the experts involved in both 
processes is essential and encouraged ECHA and EFSA to consider this need when 
establishing their processes. The ideal solution, particularly for borderline cases, would be to 
organize a single detailed expert discussion that could feed into both processes. The 
working procedures from RAC and EFSA already allow the participation of invited experts 
and a set of consultations with the committees. ECHA and EFSA were requested to 
coordinate the involvement of the relevant experts, ensuring that all relevant information is 
available to the experts, and to establish mechanisms for facilitating the exchange of views 
among the experts early in the process for identifying divergent interpretations, and 
organize ad hoc expert discussion platforms in order to try to get consensus on the scientific 
interpretation of the data. 
The rapporteur MS under the PPP Regulation, acting as dossier submitter for the CLH 
dossier, plays a key role in both processes. It is essential that when reporting the studies’ 
results, weight of evidence and its comparison with the CLP criteria, the MS experts 
consider specifically the RAC needs and previous opinions on similar cases. Following the 
RAC decision, the RAC Manual of Conclusions and Recommendations will be available to 
the CAs in order to facilitate this process.    
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5. Main conclusions and recommendations 
This chapter includes a summary of the main conclusions agreed upon by the different 
breakout groups and a table presenting the main recommendations for actions to follow up.  
It has to be underlined that the information below refers to those conclusions and 
recommendations made most frequently by the experts in the breakout groups’ sessions and 
in plenary. 
The main conclusions of the workshop can be summarized as follows:  
 need to inform ECHA as early as possible on a potential candidate for CLH 
classification; 
 call for prioritization of proposals for harmonized classification and labelling 
suggesting classification as CMR; 
 the importance of increased cooperation and awareness among the different competent 
authorities; 
 ensure consistency with respect to information evaluated under both processes and 
harmonization of the currently different formats for hazard assessment; 
 progress toward a harmonized electronic system for submission of data; 
 the relevance of the proper presentation of evidence related to hazard identification and 
comparison with CLP criteria for harmonized interpretation on CMR studies;  
 harmonized reporting on CMR studies and integration into the current reporting 
formats under the two processes. 
The workshop concluded that in the long-term "one substance, one dossier, one procedure 
and one discussion" would be the ideal situation.  
Disclaimer 
This document is based on the workshop report as published in the SANCO webpage which 
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members of the European Commission DG Health and Consumers, of the European 
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States’ representatives. It does not necessarily reflect the views of the Commission Services, 
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